GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (BOM:543329) » Definitions » Additional Paid-In Capital

Windlas Biotech (BOM:543329) Additional Paid-In Capital : ₹0 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech Additional Paid-In Capital?


Windlas Biotech's annual additional paid-in capital declined from Mar. 2022 (₹2,269 Mil) to Mar. 2023 (₹1,991 Mil) and declined from Mar. 2023 (₹1,991 Mil) to Mar. 2024 (₹1,951 Mil).


Windlas Biotech Additional Paid-In Capital Historical Data

The historical data trend for Windlas Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech Additional Paid-In Capital Chart

Windlas Biotech Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
Get a 7-Day Free Trial 754.91 754.91 2,269.47 1,990.52 1,950.93

Windlas Biotech Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,950.93 - - -

Windlas Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Windlas Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Windlas Biotech Business Description

Traded in Other Exchanges
Address
Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech Headlines

No Headlines